Pharmaceutical

Study suggests diabetes screening should be guided by a...

Asian Americans and other ethnic minorities tend to develop diabetes at lower BM...

Directly observed therapy for TB treatment, via video, ...

New York City, with one of the highest TB rates in the U.S., found that video DO...

STAT+: J&J loses a patent battle in India over a crucia...

The Indian patent office has rejected Johnson & Johnson's bid to extend a monopo...

Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Re...

What would Jonas Salk say if he were here right now? And how do you know when an...

Opinion: There is no epidemic of autism. It’s an epidem...

The more autism we recognize, the more people we can help.

Tuberculosis cases nearly back to pre-pandemic levels, ...

Early in the Covid-19 pandemic, new diagnoses of tuberculosis dropped like a sto...

STAT+: Pharmalittle: FDA panel backs conditional approv...

A FDA advisory panel concluded that a Biogen treatment for a rare, genetic form ...

STAT+: Key senators blast Medicare Advantage insurers f...

Sens. Elizabeth Warren, Jeff Merkley are blasting Medicare Advantage insurers fo...

‘It’s a universal experience’: Doctor who treats Boston...

Physician Jim O'Connell says his nonprofit is "not solving homelessness, but car...

Former surgeon general Jerome Adams tries to outrun the...

Former surgeon general Jerome Adams has emerged as a leading voice on public hea...

STAT+: Drugmakers push back on a clever tactic employer...

Health plan sponsors are excluding pricey specialty drugs from coverage, then ta...

Pfizer acquires ADC pioneer Seagen for $43bn

Seagen generated almost $2bn in revenue in 2022, an increase approaching 25% fro...

Biotech’s post-IPO boom: rebounding from a 2022 Low?

In 2022, the biotech IPO market saw fewer offerings, and those that did manage t...

Biohaven licenses Hangzhou Highlightll’s BHV-8000 to tr...

Biohaven is expecting to advance Hangzhou Highlightll’s BHV-8000 into a Phase I ...

New medications for PCOS slowly edge toward development

While lifestyle modifications play a key role in treating PCOS, the paucity of n...

US FDA approves Incyte’s merkel cell carcinoma therapy

Incyte’s Zynyz is approved based on the data obtained from the POD1UM-201 trial.